The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor.
about
The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The effect of hepatic or renal ...... ransporter reuptake inhibitor.
@en
The effect of hepatic or renal ...... ransporter reuptake inhibitor.
@nl
type
label
The effect of hepatic or renal ...... ransporter reuptake inhibitor.
@en
The effect of hepatic or renal ...... ransporter reuptake inhibitor.
@nl
prefLabel
The effect of hepatic or renal ...... ransporter reuptake inhibitor.
@en
The effect of hepatic or renal ...... ransporter reuptake inhibitor.
@nl
P2093
P2860
P1476
The effect of hepatic or renal ...... ransporter reuptake inhibitor.
@en
P2093
Debra Luffer-Atlas
Eshetu Tesfaye
Malcolm I Mitchell
Michael A Turik
William Kielbasa
P2860
P2888
P304
P356
10.1007/S00228-013-1572-Y
P577
2013-08-17T00:00:00Z